- Home
- RCUS vs IE Comparison
RCUS vs IE Comparison
Compare RCUS & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- IE
- Stock Information
- Founded
- RCUS 2015
- IE 2020
- Country
- RCUS United States
- IE United States
- Employees
- RCUS N/A
- IE N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- IE Metal Mining
- Sector
- RCUS Health Care
- IE Basic Materials
- Exchange
- RCUS Nasdaq
- IE Nasdaq
- Market Cap
- RCUS 906.4M
- IE 1.0B
- IPO Year
- RCUS 2018
- IE 2022
- Fundamental
- Price
- RCUS $9.60
- IE $11.79
- Analyst Decision
- RCUS Buy
- IE Strong Buy
- Analyst Count
- RCUS 8
- IE 3
- Target Price
- RCUS $20.86
- IE $12.67
- AVG Volume (30 Days)
- RCUS 891.1K
- IE 1.6M
- Earning Date
- RCUS 08-07-2025
- IE 08-06-2025
- Dividend Yield
- RCUS N/A
- IE N/A
- EPS Growth
- RCUS N/A
- IE N/A
- EPS
- RCUS N/A
- IE N/A
- Revenue
- RCUS $141,000,000.00
- IE $3,276,000.00
- Revenue This Year
- RCUS N/A
- IE $64.50
- Revenue Next Year
- RCUS $28.73
- IE $0.73
- P/E Ratio
- RCUS N/A
- IE N/A
- Revenue Growth
- RCUS N/A
- IE N/A
- 52 Week Low
- RCUS $6.50
- IE $4.50
- 52 Week High
- RCUS $18.98
- IE $12.05
- Technical
- Relative Strength Index (RSI)
- RCUS 53.46
- IE 72.93
- Support Level
- RCUS $9.14
- IE $11.00
- Resistance Level
- RCUS $9.62
- IE $11.83
- Average True Range (ATR)
- RCUS 0.44
- IE 0.56
- MACD
- RCUS 0.04
- IE 0.11
- Stochastic Oscillator
- RCUS 62.85
- IE 86.64
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About IE Ivanhoe Electric Inc.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.